Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
SOLARA
₹568.90
₹546.30
₹601.00
₹422.00
₹734.40
Markets Today
Historical Performance
As of 10-07-2026 22:18, Solara Active Pharma Sciences Ltd. share price today is ₹0, with a change of ₹-566.85 (-100.00%) from the previous close of ₹566.85. The stock opened at ₹566.15 and traded between ₹546.3 and ₹601, with a total traded volume of 838612 shares. The company has a market capitalization of ₹2723.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹734.4 and ₹422, respectively.
Solara Active Pharma Sciences Ltd. valuation metrics include a P/E ratio of -367.6, EPS of ₹-1.68, and book value of ₹2.20. Profitability indicators show ROE of -0.59%. Solara Active Pharma Sciences Ltd. has reported revenue of ₹1368.98 Cr and net profit of ₹-7.41 Cr.
Solara Active Pharma Sciences Ltd. technical indicators include Day RSI at 51.29, Day MFI at 60.78, Day ADX at 31.41. Additional indicators include Commodity Channel Index (CCI) at -60.2 and Williams %R at -73.36. Momentum indicators show Day MACD at 3.17, Day MACD Signal Line at 6.54, DayATR at 23.89. Rate of Change indicators for Solara Active Pharma Sciences Ltd. include ROC125 at -2.61 and ROC21 at -2.27.
Exponential moving averages include EMA5 at ₹564.8, EMA10 at ₹567, EMA12 at ₹567.6, EMA20 at ₹566.8, EMA26 at ₹564.4, EMA50 at ₹550.7, EMA100 at ₹537.3, EMA200 at ₹541.1. Simple moving averages include SMA5 at ₹564.5, SMA10 at ₹567.6, SMA20 at ₹575.3, SMA30 at ₹565.6, SMA50 at ₹551.5, SMA100 at ₹509.8, SMA150 at ₹522.8, SMA200 at ₹541.
Support levels for Solara Active Pharma are placed at First Support ₹553.97, Second Support ₹541.08, Third Support ₹526.17. Resistance levels are seen at First Resistance ₹581.77, Second Resistance ₹596.68, Third Resistance ₹609.57. Solara Active Pharma Sciences Ltd. shareholding pattern shows promoter holding at 42%, FII holding at 11.59%, DII holding at 0%, public holding at 42.66%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 387.29 | 349 | 313.54 | 319.15 | 273.01 |
| Operating Expense | 329.74 | 311.65 | 278.79 | 262.12 | 230.42 |
| Operating Profit | 57.55 | 37.35 | 34.75 | 57.03 | 42.59 |
| Depreciation | 26.04 | 25.57 | 24.49 | 23.58 | 24.30 |
| Interest | 27.06 | 22.45 | 20.83 | 23.90 | 29.12 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 9.73 | -17.42 | -10.08 | 10.53 | -4.88 |
₹568.90
↗ Bullish Moving Average
12
↘ Bearish Moving Average
4
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 37.2 | 37.9 | 42 | 42 | 42 | 42 |
| FII | 14.7 | 14.6 | 14.2 | 13.6 | 12 | 11.6 |
| DII | 3.2 | 2.6 | 2.7 | 2.7 | 3.6 | 3.7 |
| Public | 44.9 | 44.8 | 41.1 | 41.7 | 42.4 | 42.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.13 L | 3.73 L | 57.04% |
| Week | 1.22 L | 2.38 L | 51.17% |
| 1 Month | 1.11 L | 2.81 L | 39.43% |
| 6 Month | 66.29 K | 2.01 L | 33.06% |
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Relative Outperformance versus Industry over 1 Month
Expensive Performers (DVM)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Stock with Low PE (PE < = 10)
High Volume, High Gain
Top Gainers
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Aug, 2021 | 3 | FINAL | Equity Share | |
| 19 Nov, 2020 | 4 | INTERIM | 20 Nov, 2020 | Equity Share |
| 28 Jul, 2020 | 2 | FINAL | Equity Share | |
| 06 Aug, 2019 | 5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹587.60 | ₹5.40 | ₹179.17 | ₹15.60 | ₹535 | ₹62 |
| % Change | -1.43% | -0.18% | -2.00% | 0.84% | -0.10% | -0.26% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | -1.30 | 47.70 | 29.60 | 26.70 | -103.00 |
| 1 Year Return | 52.07 | 441 | 45.1 | 70 | -25.38 | -41.91 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Dishman Carbogen Amcis Ltd.
₹ 195.49
+1.38%
Lasa Supergenerics Ltd.
₹ 7.52
+1.21%
Advanced Enzyme Technologies Ltd.
₹ 330.00
+1.74%
Bajaj Healthcare Ltd.
₹ 345.50
-1.31%
Ortin Global Ltd.
₹ 16.50
+1.10%
Brooks Laboratories Ltd.
₹ 69.90
-0.87%
RPG Life Sciences Ltd.
₹ 2861.10
+7.69%
Bafna Pharmaceuticals Ltd.
₹ 204.61
+2.00%
Alpa Laboratories Ltd.
₹ 68.70
+0.60%
SMS Pharmaceuticals Ltd.
₹ 403.00
-0.99%
Nectar Lifesciences Ltd.
₹ 11.21
-0.18%
Mangalam Drugs and Organics Ltd.
₹ 27.75
+1.80%
Indoco Remedies Ltd.
₹ 259.00
+1.53%
Ind-Swift Laboratories Ltd.
₹ 247.05
+4.87%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
+0.01%
Panacea Biotec Ltd.
₹ 546.00
-1.66%
Medicamen Biotech Ltd.
₹ 244.00
-0.57%
Themis Medicare Ltd.
₹ 117.59
+1.33%
By signing up I certify terms, conditions & privacy policy